Literature DB >> 9781533

Molecular and clinical studies in SCA-7 define a broad clinical spectrum and the infantile phenotype.

C S Benton1, R de Silva, S L Rutledge, S Bohlega, T Ashizawa, H Y Zoghbi.   

Abstract

OBJECTIVE: To screen for the SCA-7 mutation in autosomal dominant cerebellar ataxia (ADCA) families and study genotype/phenotype correlations.
BACKGROUND: The association of cerebellar ataxia and progressive pigmentary macular dystrophy clinically defines a distinct form of ADCA classified as SCA-7. SCA-7 is caused by expansion of a highly unstable CAG repeat that lies in the coding region of a novel gene on chromosome 3p12-13.
METHODS: We screened 51 ADCA kindreds, in which SCA-1, SCA-2, SCA-3, and SCA6 mutations had been excluded, for the SCA-7 mutation using primers that specifically amplify the SCA-7 CAG repeat.
RESULTS: The SCA-7 mutation was identified in 10 independent families. Normal alleles ranged from 7 to 16 repeats; expanded alleles ranged from 41 to 306 repeats. One allele with 36 repeats was found in an asymptomatic individual carrying an at-risk haplotype. SCA-7 presents a wide spectrum of clinical features including visual loss, dementia, hypoacusia, severe hypotonia, and auditory hallucinations. Juvenile SCA-7 occurs on maternal and paternal transmission of the mutation, whereas the infantile form occurs only on paternal transmission. An infant of African American descent carried the largest SCA-7 expansion (306 CAG repeats) and had severe hypotonia, congestive heart failure, patent ductus arteriosus, cerebral and cerebellar atrophy, and visual loss.
CONCLUSION: These data show a wide spectrum of phenotypic abnormalities in SCA-7 and define an infantile phenotype caused by the largest CAG repeat expansion described to date.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9781533     DOI: 10.1212/wnl.51.4.1081

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  37 in total

1.  Large de novo expansion of CAG repeats in patient with sporadic spinocerebellar ataxia type 7.

Authors:  Peter Bauer; Josef Kraus; Vaclav Matoska; Martina Brouckova; Alena Zumrova; Petr Goetz
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

2.  Large pathogenic expansions in the SCA2 and SCA7 genes can be detected by fluorescent repeat-primed polymerase chain reaction assay.

Authors:  Claudia Cagnoli; Giovanni Stevanin; Chiara Michielotto; Giovanni Gerbino Promis; Alessandro Brussino; Patrizia Pappi; Alexandra Durr; Elisa Dragone; Michelle Viemont; Cinzia Gellera; Alexis Brice; Nicola Migone; Alfredo Brusco
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

3.  Evidence of white matter involvement in SCA 7.

Authors:  Marcella Masciullo; Anna Modoni; Maria Grazia Pomponi; Tommaso Tartaglione; Benedetto Falsini; Pietro Tonali; Gabriella Silvestri
Journal:  J Neurol       Date:  2006-09-19       Impact factor: 4.849

4.  Spinocerebellar ataxia type 7 presenting as Stargardt's disease.

Authors:  Georgios Tsivgoulis; Sofia Vassilopoulou; Konstntinos Rallis; Nikolaos Markomichelakis; Konstantinos Spengos
Journal:  J Neurol       Date:  2007-12-20       Impact factor: 4.849

5.  Somatic instability of expanded CAG repeats of ATXN7 in Japanese patients with spinocerebellar ataxia type 7.

Authors:  Satoshi Katagiri; Takaaki Hayashi; Tomokazu Takeuchi; Hisashi Yamada; Tamaki Gekka; Kiyokazu Kawabe; Akira Kurita; Hiroshi Tsuneoka
Journal:  Doc Ophthalmol       Date:  2015-02-03       Impact factor: 2.379

Review 6.  Non-B DNA structure-induced genetic instability and evolution.

Authors:  Junhua Zhao; Albino Bacolla; Guliang Wang; Karen M Vasquez
Journal:  Cell Mol Life Sci       Date:  2009-09-01       Impact factor: 9.261

7.  A comprehensive clinical and genetic study of a large Mexican population with spinocerebellar ataxia type 7.

Authors:  L Velázquez-Pérez; C M Cerecedo-Zapata; O Hernández-Hernández; E Martínez-Cruz; Y S Tapia-Guerrero; R González-Piña; J Salas-Vargas; R Rodríguez-Labrada; R Gurrola-Betancourth; N Leyva-García; B Cisneros; J J Magaña
Journal:  Neurogenetics       Date:  2014-10-16       Impact factor: 2.660

8.  Diagnosis of five spinocerebellar ataxia disorders by multiplex amplification and capillary electrophoresis.

Authors:  Michael O Dorschner; Deborah Barden; Karen Stephens
Journal:  J Mol Diagn       Date:  2002-05       Impact factor: 5.568

9.  Effects of Physical Rehabilitation in Patients with Spinocerebellar Ataxia Type 7.

Authors:  Karla Tercero-Pérez; Hernán Cortés; Yessica Torres-Ramos; Roberto Rodríguez-Labrada; César M Cerecedo-Zapata; Oscar Hernández-Hernández; Nelson Pérez-González; Rigoberto González-Piña; Norberto Leyva-García; Bulmaro Cisneros; Luis Velázquez-Pérez; Jonathan J Magaña
Journal:  Cerebellum       Date:  2019-06       Impact factor: 3.847

Review 10.  Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration.

Authors:  Gwenn A Garden; Albert R La Spada
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.